Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY).
Fabrizio VernieriLuigi Francesco IannoneSimona GuerzoniAntonio RussoPiero BarbantiGrazia SancesSabina CevoliRenata RaoCarlo LovatiAnna AmbrosiniCarlotta BuzzoniFederico BattistiLaura VatteoneSteffy Martin Luther KingFederico TorelliPublished in: Neurology and therapy (2024)
The results of this Italian real-world study confirmed that galcanezumab has a rapid onset of effect and provides a long-term response among patients over different migraine-related burdens. The use of healthcare resources was also remarkably reduced.